Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Josef R. Patsch, MD
JCP
Letter to the Editor
Is Second-Generation Antipsychotic-Induced Hyperprolactinemia Due to Biologically Active Prolactin or to Biologically Inactive Macroprolactin? Results From a Prospective Study
February 16, 2009
Alexander Tschoner
,
Julia Engl
,
Maria A. Rettenbacher
, et al
JCP
Original Research
Effect of Mirtazapine Treatment on Body Composition and Metabolism
March 15, 2006
Markus Laimer
,
Karin Kramer-Reinstadler
,
Markus Rauchenzauner
, et al
JCP
Original Research
Olanzapine Induces Insulin Resistance: Results From A Prospective Study
December 15, 2003
Christoph F. Ebenbichler
,
Markus Laimer
,
Ursula Eder
, et al
